Seikagaku Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seikagaku with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.69 billion Japanese Yen [US$333.69 million]
of which 97%
was Pharmaceutical Business),
Eiken Chemical Co., Ltd.
(33.27 billion Japanese Yen [US$311.11 million]
of which 54%
was Immunoserology Test Agent), and
Koei Chemical Company, Limited
(17.28 billion Japanese Yen [US$161.56 million]
Seikagaku reported sales of ¥29.59 billion (US$276.66 million)
March of 2017.
decrease of 4.4%
versus 2016, when the company's sales were ¥30.96 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Seikagaku had sales
of ¥27.08 billion.
Contributing to the drop in overall sales was the 5.4% decline
in Pharmaceutical Products, from ¥25.52 billion to ¥24.15 billion.
There were also decreases in sales in
Lal (down 0.1% to ¥5.44 billion)